Back to search

Switzerland· 31954002

Fluimucil 20 %, soluzione per infusione

A acetylcysteine product, registered in Switzerland by Zambon Svizzera SA and dispensed under Swissmedic category B. The same ATC class is registered in 7 of our 19 countries.

Cat B (Swissmedic)ATC V03AB23

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedFluimucil 20 %, soluzione per infusio…ATCV03AB23REGISTER NO.31954002PACKS LISTED0CHECKEDJune 26, 2026

Where it is registered

Acetylcysteine is registered in 7 of 19 countries.

Countries holding a registration under ATC V03AB23 (acetylcysteine), each read from that country’s own register.

  • This record: Switzerland
  • 4 of them publish a price we can compare per daily dose

Acetylcysteine · ATC V03AB23

7 / 19 countries

  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Manufacturer
Zambon Svizzera SA
Country
Switzerland (CH)
ATC code
V03AB23
ATC class
Acetylcysteine
Swissmedic category
B
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

314 interactions on record for acetylcysteine.

Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Acetylcysteine · interactions on record

314 records

  • 5 moderate
  • 2 minor
  • 307 info

Most severe, free to view

  • Insulin (human)A10AB01moderate
  • Insulin (human)A10AC01moderate
  • Insulin (human)A10AD01moderate
  • Insulin (human)A10AE01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/249c1f7e-79f1-42be-ad9c-30d8959b02e3
GET /v1/drugs/249c1f7e-79f1-42be-ad9c-30d8959b02e3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}

See everything about acetylcysteine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.